LianBio
LIANY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $11 | $35 | $60 | $159 |
| G&A Expenses | $0 | $0 | $66 | $37 |
| SG&A Expenses | $27 | $63 | $65 | $37 |
| Sales & Mktg Exp. | $0 | $0 | -$1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $38 | $98 | $124 | $195 |
| Operating Income | -$39 | -$100 | -$125 | -$196 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $41 | $411 | $15 | -$0 |
| Pre-Tax Income | $2 | $312 | -$110 | -$196 |
| Tax Expense | -$0 | $0 | -$0 | $1 |
| Net Income | $2 | $311 | -$110 | -$197 |
| % Margin | – | – | – | – |
| EPS | 0.023 | 2.88 | -1.02 | -1.83 |
| % Growth | -99.2% | 382.4% | 44.3% | – |
| EPS Diluted | 0.023 | 2.87 | -1.02 | -1.83 |
| Weighted Avg Shares Out | 108 | 108 | 108 | 107 |
| Weighted Avg Shares Out Dil | 109 | 108 | 108 | 107 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $13 | $4 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $3 | $313 | -$109 | -$196 |
| % Margin | – | – | – | – |